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[57] ABSTRACT 
Water soluble glucuronic acid derivatives of Vitamin 
A, including retinoyl B-glucui'onide and retinyl B 
glucuronide, having in vivo activity comparable to 
retinoic acid and retinol and methods of their prepara 
tion are disclosed. 
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METHOD OF PRODUCING WATER-SOLUBLE 
GLUCURONIC ACID DERIVATIVES OF VITAMIN 
A 
The invention described herein was made in the 
course of work under two grants from Competitive 
Research Grant, Science and Education Administra 
tion, U.S. Department of Agriculture grant no. 84 
CRCR-l-l4l8 and NIH grant no. AM 32793. 
BACKGROUND OF THE INVENTION 
The glucuronic acid derivatives of retinol and reti 
noic acid were ?rst obtained as biliary metabolites of 
vitamin A (Dunagin et al. Science, 148: 86-87, 1965; 
Zachman et al. J. Lipid Res. 7: 3-9, 1966; Lippel and 
Olson, J. Lipid Res. 9: 580-586, 1968). The physiolog 
ical signi?cance of these glucuronides are not known 
yet, but recent ?ndings of the presence of retinoyl glu 
curonide in the small intestine (Zile et al. J. Biol. Chem. 
257: 3544-3550, 1982) and in the liver (McCormick et 
al. Biochemistry, 22: 3933-3940, 1984) suggest that the 
glucuronides of vitamin A might play some important 
role in the overall metabolism of vitamin A. Using very 
small quantities of natural retinoyl glucuronide, it was 
shown that the compound is biologically more active 
than retinoic acid in the vaginal smear assay (Sietsema 
and DeLuca, J. Nutr. 112: 1481-1489, 1982), and 
30-100% as active as retinoic acid in the rat growth 
assay (Nath and Olson, J. Nutr. 93: 461-469, 1965). 
Blindness resulting from vitamin A de?ciency is a 
world-wide public health problem. Vitamin A de? 
ciency occurs when body stores are exhausted and sup 
ply fails to meet the body’s requirements, either because 
there is a dietary insuf?ciency, requirements are in 
creased, or absorption and use are impaired. Vitamin A 
and all the known derivatives, except the glucuronides, 
are insoluble in water; they are lipid soluble and are 
absorbed and transported using a mechanism similar to 
the one used by lipids. Like all other exogenous and 
endogenous lipids that enter the gastrointestinal tract, 
vitamin A requires solubilization into mixed-micellar 
solutions before ef?cient absorption can occur (Under 
wood, in Retinoids, vol. 1, p. 281-392, ed. Sporn et al. 
Academic Press, Orlando, Fla., 1984). With the avail 
ability of a water-soluble derivative of vitamin A, the 
problem of absorption and transport of vitamin A is 
overcome. 
Several retinoids, retinoic acid in particular, have 
been found very effective in the topical treatment and 
cure of xerophthalmia and corneal epithelial wounds 
(Ubels et al. Current Eye Res. 4: 1049-1057, 1985). 
These retinoids being water-insoluble pose signi?cant 
problems in the formulation of a suitable vehicle for the 
clinical use. With the availability of water-soluble glu 
curonide derivatives, the formulation problem is over 
come, since these derivatives could be applied as aque 
ous eye drops. 
The ?rst chemical synthesis of retinoyl B-glucuro 
nide was reported by us (Barua & Olson, J. Lipid Res. 
26: 1277-1282, 1985), and involves a two-step proce 
dure. Retinoyl ?uoride was allowed ?rst to react with 
6,3-glucuronolactone to produce the 6,3-lactone of re 
tinoyl glucuronic acid, which was then hydrolysed with 
very dilute alkali to give retinoyl B-glucuronide. The 
present invention is an improvement over the two-step 
procedure. 
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SUMMARY OF THE INVENTION 
The present invention provides a method of produc 
ing water soluble derivatives of vitamin A. More specif 
ically, it relates to a method of synthesizing retinyl 
,B-glucuronide and a one step method of synthesizing 
retinoyl B-glucuronide. The desired water soluble de 
rivatives of vitamin A can be synthesized directly from 
retinoyl ?uoride and glucuronic acid at 60% or better 
yields using a mild alkaline pH and room temperature. v 
DETAILED DESCRIPTION 
The chemical structures of retinol (I) retinyl l3 
glucuronide (II), retinoic acid (III) and retinoyl l3 
glucuronide (IV) are shown as follows. 
OH 
retinol 
II 
HO 
OH 
0 COOH 
retinyl B-glucuronide 
III 
WCOOH \ \ \ \ 
retinoic acid 
IV 
ll HO 
OH 
O coon 
retinoyl B-glucuronide 
The presence of the glucuronic acid moiety renders 
the compounds water-soluble. 
The starting material for the synthesis of retinoyl 
B-glucuronide is retinoyl ?uoride. Our U.S. Pat. No. 
4,473,503 describes the preparation of retinoyl ?uoride 
and is incorporated herein by references. Retinoyl fluo 
ride, unlike most acyl chlorides, is stable in aqueous 
solution for several days and is hydrolyzed to retinoic 
acid only on heating in the presence of alkali or acid. It 
is not appreciably hydrolyzed to retinoic acid even in 
the presence of bicarbonate at 35"-40° C. 
Retinoyl ?uoride has the following structure: 
H H H 
CH3 
Retinoyl ?uoride can be mixed with commercially 
available glucuronic acid. The reaction is carried out in 
acetone/water to facilitate the solubility of the water 
insoluble retinoyl ?uoride and the water-soluble glucu 
ronic acid. The reaction takes place in slightly alkaline 
pH and hence sodium bicarbonate is used in the reaction 
mixture. Stirring the mixture at room temperature for v 
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20-24 hours followed by acidi?cation of the solution 
and extraction with ethyl acetate yields retinoyl glucu 
ronide as the major product. Pure all-trans retinoyl 
B-glucuronide can be obtained by a combination of 
column and high-performance liquid chromatography 
(HPLC). 
The starting materials for the preparation of retinyl 
B-glucuronide include retinol that can be obtained as an 
oil by saponi?cation of commercially available retinyl 
acetate, and methyl (2,3,4-tri-O-acetyl glucopyranosyl 
bromide)-uronate that can be synthesized from com 
mercially available 6,3-glucuronolactone by known 
procedures (Bollenback et al. J. Amer. Chem. Soc. 77: 
3310-3315, 1955). The reaction is carried out in the 
presence of silver carbonate by stirring at room temper 
ature for 20-24 hours. The resulting product is a mix 
ture of unconverted retinol and the fully protected 
glucuronide of retinol. To obtain the free glucuronide, 
the crude mixture is saponi?ed without separating the 
other products and then the products are separated by a 
combination of column chromatography and HPLC. 
Compounds to which this invention relate are useful 
by reason of their valuable pharmacological properties. 
The biological activities of retinoyl B-glucuronide and 
retinyl B-glucuronide were determined with respect to 
retinoic acid and retinyl acetate, respectively. The 
glucuronides were found to be comparable in activity to 
that of retinoic acid and retinyl acetate. 
Weanling male rats (Holtzman) were made vitamin A 
de?cient by raising them on a vitamin A de?cient diet 
for 4-5 weeks. When the rats reached weight-plateau 
stage, they were divided into ?ve groups: Group I re 
ceived 2.5 pg of all-trans retinoic acid/rat twice daily. 
Group II received 2.5 pg of all-trans retinoyl B 
glucuronide/rat twice daily. Group III received 4.6 pg 
of all-trans retinyl acetate/rat twice daily. Group IV 
received 70 pg of all-trans retinyl B-glucuronide/rat/ 
week by intraparetoneal injection. Rats of Group V did 
not receive any supplement and lost weight at the end 
of the bioassay period. Rats in the other four groups 
grew almost at the same rate (Table 1). 
TABLE 1 
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stearate, magnesium oxide, sodium and calcium salts of 
phosphoric and sulfuric acid, gelatin, acacia, sodium 
algenate, polyvinyl pyrrolidone, and/or polyvinyl alco 
hol, and thus tableted or encapsulated for convenient 
administration; alternatively, they may be dissolved or 
suspended in water or comparably in aqueous liquid. 
Parenteral administration may be effective via sterile 
?uid admixture with water, polyethylene glycol, propy 
lene glycol, ethanol, corn oil, cottonseed oil, peanut oil, 
sesame oil, benzyl alcohol, sodium chloride, and/or 
various buffers. Other adjuvants and modes of adminis 
tration are well and widely known in the pharmaceuti 
cal art; see, for example, F. W. Markin, et al., “Reming 
ton’s Pharmaceutical Sciences”, 14 Ed., Merck Publish 
ing Co. Eaton, Pa. 1956. 
The following examples further illustrate the present 
invention. 
EXAMPLE 1 
’ Synthesis of Retinoyl Fluoride 
Three grams of retinoic acid was dissolved in 100 ml 
of warm diethyl ether. The solution was cooled to - 70“ 
C. and 1.61 g of N-diethyl—aminosulfurtri?uoride 
(DAST) dissolved in 5.0 ml of diethylether was added 
dropwise. (The DAST was supplied by Aldrich Chemi 
cal Co., Milwaukee, Wis.) The reaction mixture was 
warmed to room temperature and the solvent was re 
moved in vacuo. The orange oil was dissolved in 2 ml of 
hexane and immediately applied to a short column of 
silica gel (1.5 X 3 cm; silica gel for dry column chroma 
tography was supplied by Woelm Pharma, Eschwege, 
W. Germany, and was wet packed with hexane). Retin 
oyl ?uoride which moved as the main orange band was 
quickly eluted with a mixture of hexane/diethylether 
(9:1). The solvent was removed to give three grams of 
oil. Upon dissolving the oil in the minimum volume of 
hexane, and storing the solution at —20° C., orange-yel 
low crystals (2.4 g) m.p. 65°-67° C. were obtained: Amax 
378 nm (hexane), E1 cm1%= 1650. 
EXAMPLE 2 
Biological activity of all-trans retinoyl B-glucuronide 
Amount dosed Weight gain Biological 
Compound dosed itg/rat/d g/wk/rat activity 
all-trans retinoic acid 5.0 20.16 i 3.58 100%1 l00%2 
all-trans retinoyl 5.0 17.13 i 3.50 85%‘ 135%2 
B-glucuronide 
all-trans retinyl acetate 9.2 35.80 i 10.35 100%1 100%3 
all-trans retinyl 10.0 37.l6 i 4.91 l04%1 130%3 
B-glucuronide 
1Based on weight of the compound 
2Based on retinoic acid equivalent 
3Based on retinol equivalent 
The results are, of course, speci?ed merely for the 
purposes of illustration and, accordingly, are not to be 
construed as either delimiting or exclusionary. Appro 
priate dosages in any given instance, of course, depend 
upon the nature and severity of the condition treated, 
the route of administration, and the species of mammal 
involved including its size and any individual idiosyn 
cracies which obtain. 
For therapeutic purposes, the compounds of this 
invention are ordinarily combined with one or more 
adjuvants appropriate to the indicated route of adminis 
tration. If per os, they may be admixed with lactose, 
sucrose, starch powder, cellulose esters of alkanoic 
acids, cellulose alkyl ethers, talc, steric acid, magnesium 
55 
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Synthesis of retinoyl B-glucuronide 
Retinoyl ?uoride (2.4 g) was dissolved in 300 ml of 
acetone. D-Glucuronic acid (6 g) dissolved in 75 ml of 
water and sodium bicarbonate (6 g) dissolved in 75 ml of 
water were added to the retinoyl ?uoride solution. The 
mixture was stirred at room temp. for 12-16 hours. 
More water (100-150 ml) was added and the stirring 
was continued for 8-12 hours more until most of the 
retinoyl ?uoride had reacted. The solution was diluted 
with water, acidi?ed with 1N HCl, and the product was 
extracted with n-butanol. The extract was washed with 
water, dried over anhydrous sodium sulfate and then 
evaporated to dryness in a rotary evaporator. The resi-_ 
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due was dissolved in 2-3 ml of diethyl ether and trans 
ferred to a silica gel (for dry column chromatography, 
wet packed with hexane) column. The column was 
developed with hexane containing diethyl ether 
(5-50%) to remove retinoic acid and other products. 
The major yellow band containing retinoyl glucuronide 
was next eluted with a mixture of CH2Cl2/CH3OH 
(1:1). The solvent was evaporated to-dryness to give 
solid retinoyl glucuronide (2.1 g, 60%). 
An analytically pure sample of retinoyl B-glucuro 
nide was obtained by HPLC of the above preparation 
on a Whatman ODS-3 column (M9, 50 cm) using me 
thanol/water (7:3) containing 10 mM ammonium ace 
tate at a ?ow rate of 3 ml/min. Retinoyl ,B-glucuronide 
(tR=48.7 min) separated from traces of isomers or 
anomers (tR=46.4 min). The eluate carrying retinoyl 
B-glucuronide was diluted with water, made just acidic 
with 0.1N HCl and the product extracted with ethyl 
acetate. The extract was washed with water, dried over 
anhydrous sodium sulfate and then evaporated to dry 
ness. The residue was dissolved in a small volume of 
diethyl ether and all-trans retinoyl B-glucuronide was 
precipitated with hexane. The solid was separated and 
dried. all-trans Retinoyl B-glucuronidezmp. l42°-143° 
C. (darkens at 125° C.); UVmax360 nm (E1 ¢m1%= 1065) 
in methanol and 365 nm in water. The lH-NMR, IR and 
Mass spectra and C, H analysis results were consistent 
with the structure. Incubation of retinoyl B-glucuronide 
with B-glucuronidase (from E. coli) in phosphate buffer 
(pH 6.8) for 0.5-2 hrs. generated retinoic aid. 
EXAMPLE 3 
Synthesis of retinyl B-glucuronide 
Methyl (tri-O-acetyl-a-D-glucopyranosyl bromide)u 
ronate was prepared according to the method of Bollen 
back et al. (J. Amer. Chem. Soc. 77: 3310-3315, 1955). 
All-trans retinol (4.0 g) was obtained as an oil by saponi 
?cation of retinyl acetate (4.6 g). To this oil was added 
methyl (2,3,4-tri-O-acetyl-a-D-glucopyranosyl-l 
bromide)-uronate (3.2 g) and silver carbonate (1.5 g). 
The mixture was stirred in the dark at room tempera 
ture for 4-6 hours. Diethyl ether was added and the 
silver carbonate was ?ltered off. The ?ltrate was evapo 
rated to dryness. The residual oil was dissolved in 50 ml 
of methanol. To this was added 1.5 g of sodium methyl 
ate and the mixture was re?uxed at 50° C. for 10-15 
min. The solution was cooled, diluted with water, acidi 
tied with acetic acid, and the product was extracted 
with n-butanol. The extract was washed with water, 
dried over sodium sulfate and evaporated to dryness in 
a rotary evaporator. The residual oil was dissolved in 
2-3 ml of diethyl ether and transferred into a silica gel 
column (silica gel for dry column chromatography was 
wet packed with hexane). The column was developed 
with hexane containing 5—50% diethyl ether to remove 
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unconverted retinol and other side products. The col 
umn was then developed with 5-10% methanol in di 
chloromethane when a brownish-red zone was eluted. 
Development with methanol/dichloromethane (1:1) 
resulted in the elution of retinyl B-glucuronide as an 
almost colorless eluate. The fractions showing UV 
max325 nm were pooled, evaporated to dryness to yield 
a pale yellow powder of retinyl B-glucuronide (2.1 g, 
60%). To obtain an analytically pure sample of all-trans 
retinyl B-glucuronide, the residue was dissolved in 
methanol and subjected to HPLC on Whatman ODS-3 
(M9, 50 cm) column using methanol/water (4:1) con 
taining 10 mM ammonium acetate at a ?ow rate of 4 
ml/min. all-trans Retinyl B-glucuronide was eluted as 
the major peak at 15 min. The pooled eluates from 
several chromatography runs were diluted with water, 
acidi?ed with acetic acid and the product was extracted 
with ethyl acetate. The extract was washed with water, 
dried over anhyd. sodium sulfate, and then evaporated 
to dryness in a rotary evaporator. The residue was dis 
solved in a small volume of diethyl ether and all-trans 
retinyl B-glucuronide was precipitated with hexane. 
The solid was separated and dried. all-trans retinyl ,B 
glucuronide m.p. l38°—l40° C. (decom), UV max 325 ( 
ter. The NMR and mass spectra and C,H analysis results 
were consistent with the structure. 
Treatment of retinyl B-glucuronide with B 
glucuronidase (from E. Call’) in phosphate buffer (pH 
6.8) for 1-2 hours resulted in formation of retinol. 
What is claimed is: 
1. A method of producing water soluble retinoyl 
B-glucuronide comprising 
acylating water-soluble glucuronic acid by treatment 
with water-insoluble retinoyl ?uoride, and 
stirring the mixture for an effective amount of time to 
facilitate the reaction of retinoyl ?uoride with glu 
curonic acid in a mixture of about two parts ace 
tone to about one part water at an alkaline pH of 
from about 7.2 to about 8, 
acidifying the mixture and extracting the retinoyl 
glucuronide. 
2. The method of claim 1 wherein the mixture is 
stirred for about 20 to about 24 hours. 
3. The method of claim 2 wherein the mixture is 
stirred at room temperature. 
4. The method of claim 1 wherein the mixture is 
acidi?ed by adjusting the pH of the mixture to about 6 
to about 6.8. 
5. The method of claim 1 wherein the retinoyl glucu 
ronide is separated to yield retinoyl B-glucuronide. 
6. The method of claim 1 wherein the yield of retin 
oyl glucuronide is about 55 to about 60% based on 
retinoyl ?uoride. 
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